-
Je něco špatně v tomto záznamu ?
In vitro degradation and in vivo toxicity of NanoMatrix3D® polycaprolactone and poly(lactic acid) nanofibrous scaffolds
M. Pogorielov, A. Hapchenko, V. Deineka, L. Rogulska, O. Oleshko, K. Vodseďálková, L. Berezkinová, L. Vysloužilová, A. Klápšťová, J. Erben,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
29637696
DOI
10.1002/jbm.a.36427
Knihovny.cz E-zdroje
- MeSH
- krysa rodu rattus MeSH
- nanočástice toxicita MeSH
- nanovlákna toxicita MeSH
- orgánová specificita účinky léků MeSH
- polyestery toxicita MeSH
- tkáňové podpůrné struktury chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Nanofibrous materials present unique properties favorable in many biomedicine and industrial applications. In this research we evaluated biodegradation, tissue response and general toxicity of nanofibrous poly(lactic acid) (PLA) and polycaprolactone (PCL) scaffolds produced by conventional method of electrospinning and using NanoMatrix3D® (NM3D® ) technology. Mass density, scanning electron microscopy and in vitro degradation (static and dynamic) were used for material characterization, and subcutaneous, intramuscular and intraperitoneal implantation - for in vivo tests. Biochemical blood analysis and histology were used to assess toxicity and tissue response. Pore size and fiber diameter did not differ in conventional and NM3D® PLA and PCL materials, but mass density was significantly lower in NM3D® ones. Scaffolds made by conventional method showed toxic effect during the in-vivo tests due to residual concentration of chloroform that released with material degradation. NM3D® method allowed cleaning scaffolds from residual solutions that made them nontoxic and biocompatible. Subcutaneous, intramuscular and intraperitoneal implantation of PCL and PLA NM3D® electrospun nanofibrous scaffolds showed their appropriate cell conductive properties, tissue and vessels formation in all sites. Thus, NM3D® PCL and PLA nanofibrous electrospun scaffolds can be used in the field of tissue engineering, surgery, wound healing, drug delivery, and so forth, due to their unique properties, nontoxicity and biocompatibility. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2200-2212, 2018.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045497
- 003
- CZ-PrNML
- 005
- 20200115081940.0
- 007
- ta
- 008
- 200109s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jbm.a.36427 $2 doi
- 035 __
- $a (PubMed)29637696
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pogorielov, Maksym $u Sumy State University, Sumy, Ukraine.
- 245 10
- $a In vitro degradation and in vivo toxicity of NanoMatrix3D® polycaprolactone and poly(lactic acid) nanofibrous scaffolds / $c M. Pogorielov, A. Hapchenko, V. Deineka, L. Rogulska, O. Oleshko, K. Vodseďálková, L. Berezkinová, L. Vysloužilová, A. Klápšťová, J. Erben,
- 520 9_
- $a Nanofibrous materials present unique properties favorable in many biomedicine and industrial applications. In this research we evaluated biodegradation, tissue response and general toxicity of nanofibrous poly(lactic acid) (PLA) and polycaprolactone (PCL) scaffolds produced by conventional method of electrospinning and using NanoMatrix3D® (NM3D® ) technology. Mass density, scanning electron microscopy and in vitro degradation (static and dynamic) were used for material characterization, and subcutaneous, intramuscular and intraperitoneal implantation - for in vivo tests. Biochemical blood analysis and histology were used to assess toxicity and tissue response. Pore size and fiber diameter did not differ in conventional and NM3D® PLA and PCL materials, but mass density was significantly lower in NM3D® ones. Scaffolds made by conventional method showed toxic effect during the in-vivo tests due to residual concentration of chloroform that released with material degradation. NM3D® method allowed cleaning scaffolds from residual solutions that made them nontoxic and biocompatible. Subcutaneous, intramuscular and intraperitoneal implantation of PCL and PLA NM3D® electrospun nanofibrous scaffolds showed their appropriate cell conductive properties, tissue and vessels formation in all sites. Thus, NM3D® PCL and PLA nanofibrous electrospun scaffolds can be used in the field of tissue engineering, surgery, wound healing, drug delivery, and so forth, due to their unique properties, nontoxicity and biocompatibility. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2200-2212, 2018.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nanovlákna $x toxicita $7 D057139
- 650 _2
- $a nanočástice $x toxicita $7 D053758
- 650 _2
- $a orgánová specificita $x účinky léků $7 D009928
- 650 _2
- $a polyestery $x toxicita $7 D011091
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a tkáňové podpůrné struktury $x chemie $7 D054457
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hapchenko, Andrii $u Sumy State University, Sumy, Ukraine.
- 700 1_
- $a Deineka, Volodymyr $u Sumy State University, Sumy, Ukraine.
- 700 1_
- $a Rogulska, Larysa $u Medical Center "Floris", Sumy, Ukraine.
- 700 1_
- $a Oleshko, Olexandr $u Sumy State University, Sumy, Ukraine.
- 700 1_
- $a Vodseďálková, Kateřina $u Nanopharma, a.s., Nová 306, Pardubice, Czech Republic.
- 700 1_
- $a Berezkinová, Liliana $u Nanopharma, a.s., Nová 306, Pardubice, Czech Republic.
- 700 1_
- $a Vysloužilová, Lucie $u Nanopharma, a.s., Nová 306, Pardubice, Czech Republic.
- 700 1_
- $a Klápšťová, Andrea $u Nanopharma, a.s., Nová 306, Pardubice, Czech Republic.
- 700 1_
- $a Erben, Jakub $u Nanopharma, a.s., Nová 306, Pardubice, Czech Republic.
- 773 0_
- $w MED00007498 $t Journal of biomedical materials research. Part A $x 1552-4965 $g Roč. 106, č. 8 (2018), s. 2200-2212
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29637696 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200115082314 $b ABA008
- 999 __
- $a ok $b bmc $g 1483765 $s 1084170
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 106 $c 8 $d 2200-2212 $e 20180430 $i 1552-4965 $m Journal of biomedical materials research. Part A $n J Biomed Mater Res $x MED00007498
- LZP __
- $a Pubmed-20200109